Biologix is a Dubai-based firm that represents international pharma companies by bringing innovative drugs to market in the Middle East / North Africa (MENA) region. Its GM, Zeina Sfeir Lahoud, discusses the company’s presence in over 17 countries, their 25 years of experience in Saudi Arabia, and the dynamics shaping the largest market in the region, including the fast regulatory approval process in place. With value-based healthcare an increasingly hot topic, she explains how Biologix has moved to sign the first risk-sharing agreement with Saudi Arabia for a spinal muscular atrophy product; the first in the MENA region.
STAY UP TO DATE NEWS & EVENTS
Related EVENTS & NEWS
Biologix Strengthens Leadership in Hematology at 3rd Middle East Masterclass
Biologix as Silver Sponsor at Oman International Pharmacy Congress & Exhibition
Biologix has participated as a Silver Sponsor at the Oman International Pharmacy Congress & Exhibition held from January 14-16, 2024, at the Muscat Convention & Exhibition Centre in the Sultanate of Oman.
2nd Middle East Pharmacoeconomics and Drug Policy Summit
Biologix team has attended the 2nd Middle East Pharmacoeconomics and Drug Policy Summit that was held in Dubai UAE, at the Conrad Hotel on November 17th and 18th 2022. Read More ...
